Literature DB >> 15936308

Microdetermination of chondroitin sulfate in normal human plasma by fluorophore-assisted carbohydrate electrophoresis (FACE).

Nicola Volpi1, Francesca Maccari.   

Abstract

An inexpensive, simple, sensitive and reproducible analytical method for the quantitative and qualitative evaluation of chondroitin sulfate (CS) from human blood plasma samples by using fluorophore-assisted carbohydrate electrophoresis (FACE) has been developed. After treatment with a nonspecific protease to convert proteins into small peptides, CS from 100 microl of normal human plasma was extracted by using a filter membrane (molecular mass cut-off of 3000 Da) or purification by using an anion-exchange resin. The recovered CS was converted into unsaturated disaccharides through the action of chondroitin ABC lyase, derivatized with 2-aminoacridone by reductive amination in the presence of cyanoborohydride and separated by FACE. The procedure using the purification of plasma CS on the anion-exchange resin produced a cleaner separation and a better resolution of Delta-disaccharides then using microfiltration. The linearity, sensitivity and reproducibility of the method were determined in comparison with HPLC equipped with postcolumn derivatization and fluorescence detection using 2-cyanoacetamide as a fluorogenic reagent. The detection limit was calculated to be 50 ng of CS with a linear response from 50 to 2000 ng. The recovery was found greater than 85% (from 2 to 10 microg CS) with a variation coefficient of approx. 10%. Furthermore, the results obtained from 100 microl plasma were almost identical to those obtained using 20 microl, 50 microl and 200 microl. This method was applied to the characterization of CS in 33 healthy human subjects ageing from 30 to 63 years old.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936308     DOI: 10.1016/j.cccn.2005.01.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase.

Authors:  Giovanni V Coppa; Dania Buzzega; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Nicola Volpi
Journal:  JIMD Rep       Date:  2011-11-04

2.  Amelioration of human osteoarthritis symptoms with topical 'biotherapeutics': a phase I human trial.

Authors:  Fadia F Mahmoud; Adel M Al-Awadhi; David D Haines
Journal:  Cell Stress Chaperones       Date:  2014-11-27       Impact factor: 3.667

3.  Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection.

Authors:  Alicia M Hitchcock; Michael J Bowman; Gregory O Staples; Joseph Zaia
Journal:  Electrophoresis       Date:  2008-11       Impact factor: 3.535

4.  Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques.

Authors:  Elisabetta Zinellu; Antonio Junior Lepedda; Antonio Cigliano; Salvatore Pisanu; Angelo Zinellu; Ciriaco Carru; Pietro Paolo Bacciu; Franco Piredda; Anna Guarino; Rita Spirito; Marilena Formato
Journal:  Biochem Res Int       Date:  2011-12-15

5.  A Fluorescent Probe for Glycosaminoglycans Applied to the Detection of Dermatan Sulfate by a Mix-and-Read Assay.

Authors:  Melissa Rappold; Ulrich Warttinger; Roland Krämer
Journal:  Molecules       Date:  2017-05-09       Impact factor: 4.411

6.  Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement.

Authors:  Nawras Talmoudi; Noureddine Ghariani; Saloua Sadok
Journal:  Biol Proced Online       Date:  2020-01-02       Impact factor: 3.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.